共 50 条
Points to consider for reporting of germline variation in patients undergoing tumor testing: a statement of the American College of Medical Genetics and Genomics (ACMG)
被引:63
|作者:
Li, Marilyn M.
[1
]
Chao, Elizabeth
[2
]
Esplin, Edward D.
[3
]
Miller, David T.
[4
]
Nathanson, Katherine L.
[5
]
Plon, Sharon E.
[6
,7
]
Scheuner, Maren T.
[8
,9
,10
]
Stewart, Douglas R.
[11
]
机构:
[1] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Univ Calif Irvine, Sch Med, Div Genet & Genom Med, Irvine, CA 92717 USA
[3] Invitae, San Francisco, CA USA
[4] Brigham & Womens Hosp, Dept Pathol, Div Genet & Genom, 75 Francis St, Boston, MA 02115 USA
[5] Univ Penn, Perelman Sch Med, Dept Med Translat Med & Human Genet, Philadelphia, PA 19104 USA
[6] Baylor Coll Med, Houston, TX 77030 USA
[7] Texas Childrens Hosp, Houston, TX 77030 USA
[8] UCSF Sch Med, Dept Med, Dept Pediat, Div Med Genet, San Francisco, CA USA
[9] UCSF Sch Med, Dept Med, Div Hematol Oncol, San Francisco, CA USA
[10] San Francisco VA Hlth Care Syst, Clin Genet Program, San Francisco, CA USA
[11] NCI, Clin Genet Branch, Div Canc Epidemiol & Genet, Rockville, MD USA
[12] Amer Coll Med Genet & Genom, Bethesda, MD USA
关键词:
presumed germline pathogenic variants (PGPV);
somatic variants;
tumor testing;
next-generation sequencing (NGS);
secondary findings;
BREAST-CANCER;
GUIDELINE;
DISEASE;
HEALTH;
IMPACT;
GENES;
DNA;
D O I:
10.1038/s41436-020-0783-8
中图分类号:
Q3 [遗传学];
学科分类号:
071007 ;
090102 ;
摘要:
[No abstract available]
引用
收藏
页码:1142 / 1148
页数:7
相关论文